Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Jade Biosciences, Inc. (JBIO) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Jade Biosciences, Inc. (JBIO), most recent 12 months reported: net loss $153.24M, free cash flow -$94.89M. Latest balance sheet on file: liquid cash $461.2M. From SEC filings. Others in Pharmaceutical Preparations: INOVIO PHARMACEUTICALS, INC. · Inhibitor Therapeutics, Inc. · Disc Medicine, Inc. · Incannex Healthcare Inc. · KALA BIO, INC. · KAIROS PHARMA, LTD. · KIORA PHARMACEUTICALS, INC. · PASITHEA THERAPEUTICS CORP.

Stock screener

Watchlist